FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMENT OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: SEPTEMBER 15, 2019

Results 51 through 100 of 262

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
BHC New York Bausch Health Companies Inc 2834
BHVN New York Biohaven Pharmaceutical Holdin 2834
BIOC Nasdaq Biocept Inc 2834
BKIT Over the counter BioHemp International Inc 2834
BLU Nasdaq BELLUS Health Inc 2834
BMRN Nasdaq BioMarin Pharmaceutical Inc. 2834
BMY New York Bristol-Myers Squibb Co 2834
BSPK Over the counter Bespoke Extracts Inc 2834
BSTC Nasdaq BioSpecifics Technologies Corp 2834
BTHE Over the counter Boston Therapeutics Inc 2834
CALA Nasdaq Calithera Biosciences Inc 2834
CARA Nasdaq Cara Therapeutics Inc 2834
CBAY Nasdaq CymaBay Therapeutics Inc 2834
CBM New York Cambrex Corporation 2834
CBMG Nasdaq Cellular Biomedicine Group Inc 2834
CERC Nasdaq Cerecor Inc 2834
CFRX Nasdaq ContraFect Corp 2834
CHHE Over the counter China Health Industries Holdin 2834
CHMA Nasdaq Chiasma Inc 2834
CLCS Over the counter Cell Source Inc 2834
CLRB Nasdaq Cellectar Biosciences Inc 2834
CLSN Nasdaq Celsion Corporation 2834
CNST Nasdaq Constellation Pharmaceuticals 2834
COCP Nasdaq Cocrystal Pharma Inc 2834
COLL Nasdaq Collegium Pharmaceutical Inc 2834
CORT Nasdaq Corcept Therapeutics Incorpora 2834
CORV Nasdaq Correvio Pharma Corp 2834
CPHI American China Pharma Holdings, Inc. 2834
CPIX Nasdaq Cumberland Pharmaceuticals, In 2834
CPMD Over the counter Cannapharmarx Inc 2834
CPRX Nasdaq Catalyst Pharmaceuticals Inc 2834
CRBP Nasdaq Corbus Pharmaceuticals Holding 2834
CTLT New York Catalent Inc 2834
CUE Nasdaq Cue Biopharma Inc 2834
CXUS Over the counter Celexus Inc 2834
CYAN Nasdaq CYANOTECH CORP 2834
CYCC Nasdaq Cyclacel Pharmaceuticals Inc 2834
CYIG Over the counter Spring Pharmaceutical Group In 2834
DERM Nasdaq Dermira Inc 2834
DRRX Nasdaq DURECT Corporation 2834
EGRX Nasdaq Eagle Pharmaceuticals Inc 2834
ELAN New York Elanco Animal Health Inc 2834
EMMA Over the counter Emmaus Life Sciences Inc 2834
ENDP Nasdaq Endo International PLC 2834
ENTA Nasdaq Enanta Pharmaceuticals Inc 2834
EQ Nasdaq Equillium Inc 2834
ESALY Over the counter Eisai Co., Ltd (ADR) 2834
ESPR Nasdaq Esperion Therapeutics Inc 2834
ETTX Nasdaq Entasis Therapeutics Holdings 2834
EVFM Nasdaq Evofem Biosciences Inc 2834
Results 50 through 100 of 262